VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Impact of impaired glutamine/glutamate metabolic axis on osteoclast activation in multiple myeloma

Nicola Giuliani, MD, PhD, University of Parma, Parma, Italy, discusses the impact of impaired glutamine/glutamate metabolism on osteoclast formation and bone destruction, commenting on in vitro data showing that high levels of glutamate in the bone microenvironment stimulate osteoclast signaling and subsequent osteoclast activation. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter